BARI

(redirected from Bypass Angioplasty Revascularization Investigation)
Also found in: Medical.
AcronymDefinition
BARIBypass Angioplasty Revascularization Investigation (clinical trial)
BARIBangladesh Agricultural Research Institute (Joydebpur, Bangladesh)
BARIBusch Agricultural Resources, Inc. (various locations)
BARIBritish Archaeological Reports International Series
BARIBalloon Angioplasty Revascularization Investigation (cardiology)
BARIBihar Agricultural Research Institute (India)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The angiographic definitions of the bypass angioplasty revascularization investigation. Coron Artery Dis.
Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI) Circulation 1997;96:1761-9.
To examine the possible relationship between elevated troponin T and adverse CV outcomes in patients who had both stable ischemic heart disease and diabetes, the investigators performed a post hoc analysis of data gathered in the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) clinical trial, which compared outcomes between patients who underwent preventive percutaneous coronary intervention or coronary artery bypass grafting plus intensive medical therapy against those who received intensive medical therapy alone.
Andrews et al., "Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) investigators," New England Journal of Medicine, vol.
(19.) Brooks MM, Frye RL, Genuth S, Detre KM, Nesto R, Sobel BE, et al; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators.
In addition, the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D), which also studied two glucose-lowering strategies, found no difference in outcome whether the patients received insulin-providing or insulin-sensitizing therapy.